Strive Health Deepens Advisory, Culture, and AI Focus to Advance Value-Based Kidney Care

Strive Health is a value-based kidney care company, and this weekly recap highlights its renewed emphasis on clinical strategy, advisory engagement, and technology-enabled care models. This summary reviews notable developments from recent company communications and advisory board activities.

During the week, Strive convened an in-person meeting of its Clinical Advisory Board, bringing together leading nephrologists and health policy experts such as Kavita Patel, M.D. Discussions focused on how nephrology can help shape emerging value-based care models and better align incentives around patient outcomes.

Key themes from the advisory sessions included leveraging data and technology to support clinicians, designing payer partnerships that prioritize patients, and operationalizing care models built on mutual accountability. Strive indicated that it is working to synthesize clinical, policy, and payer perspectives to refine scalable, outcomes-focused kidney care programs.

The company also highlighted the complexity of the kidney care landscape, citing shifting value-based care policies, rapid technology advances, and rising performance expectations from payers. Strive’s strategy appears centered on demonstrating measurable cost savings and improved outcomes to strengthen its position in risk-based nephrology contracts.

These advisory activities build on earlier updates emphasizing culture, care coordination, and AI-enabled innovation. Strive recently showcased its internal “Why I Strive” series, underscoring cross-functional collaboration and patient engagement as foundational elements of its value-based kidney care delivery model.

The company has also promoted a “Lunch and Learn” webinar on transitional care management for kidney patients, featuring senior clinical leaders sharing best practices to reduce hospital readmissions. By emphasizing complex care coordination, Strive aims to deepen relationships with provider partners and support contract retention and expansion.

In parallel, Strive is advancing an AI strategy tailored to nephrology, noting challenges with fragmented point solutions and limited specialty-specific tools. The firm is pursuing co-developed, workflow-integrated AI solutions with provider groups to directly support value-based arrangements rather than stand-alone products.

Taken together, this week’s developments underscore Strive Health’s focus on aligning clinical advisory input, internal culture, and technology investments to strengthen its value-based kidney care platform. These efforts may enhance its ability to secure and execute risk-based contracts and support long-term growth in managed nephrology services.